Hopkins Biotech Podcast
Episodes
Sickle Cell Disease: New Wave of Gene Therapies
01 Oct 2025
Contributed by Lukas
Sickle cell disease was once considered an incurable disease, until recently. A wide variety of gene therapies have now become available, allowing pat...
Roivant: Reinventing the Paradigm of Conventional Drug Development
05 Jan 2024
Contributed by Lukas
Roivant Pharma is reinventing the discovery, development, and commercialization of new medicines. Mayukh Sukhatme, M.D. was recently appointed to Roiv...
Public Relations and Scientific Communications for Biotechnology with Ignacio Guerrero-Ros
18 Dec 2023
Contributed by Lukas
Dr. Ignacio Guerrero-Ros is an immunologist turned scientific communicator and biotech media innovator. Currently, he is an Assistant Vice President a...
What You Should Know About the Biotech Job Market in 2023 with Carina Clingman
01 Nov 2023
Contributed by Lukas
Carina Clingman, Ph.D., is the Founder and CEO of Recruitomics Consulting, a niche talent acquisition and talent strategy firm specializing in biotech...
Antibody-Drug Conjugates: Targeting Cancer Where it is Vulnerable with David Dornan of Elevation Oncology
09 Oct 2023
Contributed by Lukas
About this episode: David Dornan is the Chief Scientific Officer of Elevation Oncology, a clinical-stage biotech company developing targeted cancer th...
Boston Biotech Series: Standing out in the Competitive Recruiting Process for Early Stage Biotech
14 Aug 2023
Contributed by Lukas
Emily Gransky is the Vice President of Recruiting at RA Ventures (RAVen). RAVen is the early-stage venture arm of the multi-stage investment firm RA C...
Boston Biotech Series: Building a Drug Development Platform on New Biology with Isaac Klein of Dewpoint Therapeutics
17 Jul 2023
Contributed by Lukas
Dr. Isaac Klein is the Chief Scientific Officer at Dewpoint Therapeutics. Dewpoint Therapeutics is leveraging condensate biology to impact a wide rang...
Boston Biotech Series: Facilitating Start-up Company Formation with Adam Jenkins of Biolabs
17 Apr 2023
Contributed by Lukas
Dr. Adam Jenkins is the Regional Site Director for the Massachusetts sites of Biolabs. BioLabs is an international, membership-based network of shared...
JPM Highlights: What’s Next in ImmunoOncology
20 Mar 2023
Contributed by Lukas
In this episode, we talk with our panel about updates their company gave at the recent JP Morgan Healthcare Conference that took place earlier this ye...
Lineage Cell Therapeutics: Building an Allogeneic Cell Transplant Therapy Platform
27 Feb 2023
Contributed by Lukas
Brian Culley is the CEO of Lineage Cell Therapeutics, a clinical-stage biotech company whose mission is to pioneer a new branch of medicine based on t...
JPM Highlights: Overcoming Complications in Rare Disease Drug Development
15 Feb 2023
Contributed by Lukas
In this episode, we talk with our panel about updates their company gave at the recent JP Morgan Healthcare Conference that took place earlier this ye...
Adrian Rubstein: translating science to business in the Latin American biotech ecosystem
17 Jan 2023
Contributed by Lukas
Adrian is an advisor for several biotech companies in Argentina. Before joining CITES, a venture builder from Argentina, he worked as an advisor for R...
Cyclacel Pharmaceuticals: Interventions for Cell Cycle Abnormalities in Cancer
09 Jan 2023
Contributed by Lukas
Cyclacel Pharmaceuticals is a clinical-stage, biopharmaceutical company, developing innovative cancer medicines based on cell cycle, transcriptional r...
Melatech: Unlocking Melanin’s Biotech Potential for the Benefit of Society in Earth and Space
05 Dec 2022
Contributed by Lukas
Radamés Cordero is the CEO of Melatech and an associate scientist and junior faculty in the department of Molecular Microbiology and Immunology at Jo...
Ratio Therapeutics: Math Meets Medicine in the Design of Radiotherapies
21 Nov 2022
Contributed by Lukas
Ratio Therapeutics is a Boston-based pharmaceutical company with the mission to accelerate the development of best-in-class targeted radiotherapeuti...
Anupam Chakravarty: Building Community in the Graduate Education Landscape
14 Nov 2022
Contributed by Lukas
Dr. Anupam Chakravarty is a researcher whose research interests have straddled the disciplines of biochemistry and genomics with a keen focus on the b...
Tony Russo: A Multi-Decade View of the Biotechnology Industry
31 Oct 2022
Contributed by Lukas
Dr. Tony Russo Ph.D. is the Chairman, CEO, and founder of Russo Partners, a leading public and investor relations firm. He has been a member of the he...
Robert Hollingsworth: The Future of iPSC-based Cell Therapy Technology
03 Oct 2022
Contributed by Lukas
Dr. Robert Hollingsworth is the current Chief Scientific Officer of Shoreline Biosciences, a biopharmaceutical company developing next-generation cell...
Shelley Ackerman: Immunotherapeutics Development in Graduate School
05 Sep 2022
Contributed by Lukas
Dr. Shelley Ackerman is an Associate Director & Program Team Lead at Bolt Biotherapeutics. Bolt is a clinical-stage biotechnology company pioneeri...
James Coates: Company Growth Through Strategic Advising
22 Aug 2022
Contributed by Lukas
Dr. James Coates is currently the Principal for Health & Human Performance at Decisive Point, an East coast venture capital firm that invests in...
Philip Kantoff: Next Generation Radiopharmaceutical Drug Development
08 Aug 2022
Contributed by Lukas
Dr. Phil Kantoff is the CEO and Co-Founder of Convergent Therapeutics, a clinical-stage pharmaceutical company focused on developing next-generation r...
Steve Doberstein: Scaling Technologies from Idea to Clinical Development
25 Jul 2022
Contributed by Lukas
Dr. Steve Doberstein has had a long career leading Research groups at a number of biotech companies, like “XOMA”- a monoclonal antibody discovery ...
Daniel Elgort: Data Driven Insights into the Drug Development Pipeline
11 Jul 2022
Contributed by Lukas
Dr. Daniel Elgort currently serves as the Chief Data and Analytics Officer for M2GEN, a bioinformatics company focused on the acceleration of oncolo...
Hong Tang: Targeting the Common Side Effects of Cancer Therapies
30 Jun 2022
Contributed by Lukas
Hong Tang is the co-founder and Chief Medical Officer of OnQuality Pharmaceuticals, a targeted cancer supportive care (TCSC) pharmaceutical company de...
Apprentice.io: The Future of Digitization in Pharmaceutical Production
21 Jun 2022
Contributed by Lukas
Laura Jacoby is currently an Application Specialist at Apprentice.io, an innovative tech company that offers cloud-based solutions that impact pharmac...
Alex Harding M.D.: Business Development of Innovative Therapeutic Modalities
16 May 2022
Contributed by Lukas
Alex Harding is a Senior Vice President of Business Development and Corporate Strategy at Remix Therapeutics, a Boston-based biotech company develop...
All about the Maryland Blue Crab! Presenting a Collaboration with The Sci'more Podcast
25 Apr 2022
Contributed by Lukas
The crab season is here! If you are a Baltimore resident, you might have enjoyed dozens of our famous blue crabs, perhaps dozens of dozens every year....
Rachel Soloff and Andrew McKnight: Pioneering Monoclonal Antibody Discovery and Development
11 Apr 2022
Contributed by Lukas
Our episode features two leaders at the global specialty pharmaceutical company Kyowa Kirin. Kyowa Kirin has a particular focus on the discovery and d...
My PhD - McKane Sharff: Research at School of Public Health
07 Mar 2022
Contributed by Lukas
McKane is a 5th year PhD student in the Department of Population, Family and Reproductive Health at Johns Hopkins Bloomberg School of Public Health S...
Boston Biotech Series: Evaluating the Pharmaceutical Landscape with Dr. Michael Nedelcovych
21 Feb 2022
Contributed by Lukas
Dr. Michael Nedelcovych is a Vice President of Equity Research at Cowen Inc., a diversified financial services firm that operates as a broker dealer a...
Eric Vivier: NK Cells and the Next Generation of Immunotherapies
07 Feb 2022
Contributed by Lukas
Eric Vivier is an SVP, CSO, and co-founder of Innate Pharma, a company developing innovative immunotherapy approaches with the goal of eradicating sol...
Boston Biotech Series: Succeeding in a Biotech Career with Dr. Michelle Ols
24 Jan 2022
Contributed by Lukas
Dr. Michelle Ols is a Director and the Head of Cell Therapy at Obsidian Therapeutics. Obsidian Therapeutics is a private, Cambridge-based biotech comp...
My PhD- Peter Chianchiano
19 Jan 2022
Contributed by Lukas
Peter is a 5th-year PhD student from the Pathobiology program at Johns Hopkins School of medicine.As part of Dr. Laura D. Wood’s lab, his thesis is ...
My PhD- Marisa Mitchell-Flack
29 Dec 2021
Contributed by Lukas
Marisa is a fourth-year PhD candidate at the Johns Hopkins University School of Medicine in the Laboratory of Dr. Drew Pardoll. After her undergrad, ...
Dr. Greg Verdine: Lessons from a Serial Entrepreneur
13 Dec 2021
Contributed by Lukas
Dr. Greg Verdine is an eminent serial entrepreneur and investor in the life sciences industry. He has founded a number of companies and currently se...
Beyond the Horizons: Leaving my PhD
02 Dec 2021
Contributed by Lukas
Beyond the Horizons is a mini podcast series about different career paths and relevant professional development topics to discover what lies beyond. J...
Beyond the Horizons: Careers in Museums
02 Dec 2021
Contributed by Lukas
Beyond the Horizons is a mini podcast series about different career paths and relevant professional development topics to discover what lies beyond. J...
Beyond the Horizons: Careers in UX Research
02 Dec 2021
Contributed by Lukas
Beyond the Horizons is a mini podcast series about different career paths and relevant professional development topics to discover what lies beyond. J...
Beyond the Horizons: Careers in Writing & Publishing
02 Dec 2021
Contributed by Lukas
Beyond the Horizons is a mini podcast series about different career paths and relevant professional development topics to discover what lies beyond. J...
Boston Biotech Series: Interviewing for Biotech R&D Positions
22 Nov 2021
Contributed by Lukas
Wei-Chiang Chen, PhD is an Associate Director of Bioprocess Analytics in the Genome Medicine Unit at Sanofi, developing cell and gene therapies for ar...
Dave Latshaw- Next Generation Healthcare Fintech
11 Nov 2021
Contributed by Lukas
Dave is the CEO and Chief Scientific Officer of BioPhy, a healthcare fintech company committed to enhancing outcomes for patients and creating value f...
Insights: Nucleate (Biotech Entrepreneurship)
25 Oct 2021
Contributed by Lukas
Soufiane Aboulhouda is the co-founder and co-president of Nucleate, a new, student-run, non-profit activator program for the next generation of biotec...
My PhD- Joe Varriale
18 Oct 2021
Contributed by Lukas
Joe is a fourth-year PhD candidate at the Johns Hopkins University School of Medicine in the Laboratory of Dr. J.N. and R.F. Siliciano. If you are a ...
C.G. Moore: IP Law and Patent Strategies
11 Oct 2021
Contributed by Lukas
C.G. Moore, Ph.D., J.D., is a Partner at McBee Moore Woodward & Vanik IP, LLC., a boutique law firm based in Alexandria, Virginia, that specialize...
My PhD- Gian Molina-Castro
04 Oct 2021
Contributed by Lukas
Gian is a fourth-year PhD candidate at the Johns Hopkins University School of Medicine in the Solomon H. Snyder Department of Neuroscience. His thesis...
Christy Wyskiel: Technology Transfer at Johns Hopkins University
27 Sep 2021
Contributed by Lukas
Christy Wyskiel is the Senior Advisor to the President of Johns Hopkins University for Innovation & Entrepreneurship and the Executive Director ...
Ben Portney - Entrepreneurial Exploration in Grad School
13 Sep 2021
Contributed by Lukas
Ben Portney, Ph.D. is a Senior Associate at Flagship Pioneering, a life sciences venture capital firm specializing in company creation for transformat...
Boston Biotech Series: Industry Resumes
30 Aug 2021
Contributed by Lukas
Patricia Phelps, PhD is the Associate Director of Academic Career Services at the Johns Hopkins School of Medicine, where she oversees professional de...
Caroline Loew, Ph.D.: Building an Innovative Biotech
16 Aug 2021
Contributed by Lukas
Caroline Loew, Ph.D. is the President and CEO of Glympse Bio, an MIT spin out company trying to change the paradigm of in vivo diagnostic and progno...
Samantha Semenkow - Biotech Valuation in the Public Markets
09 Aug 2021
Contributed by Lukas
Sam Semenkow, Ph.D. is a Director of Portfolio Intelligence at Bridge Bio, a unique biotechnology company that develops drugs in several modalities fo...
Boston Biotech Series: Finding a Position in Boston Biotech
26 Jul 2021
Contributed by Lukas
Carina Clingman, PhD is a Principal and Founder of Recruitomics Biotalent Consulting, a biotechnology hiring and recruitment agency based in Cambridge...
Johns Hopkins Alt. Protein Project: Protein of the Future
12 Jul 2021
Contributed by Lukas
In this episode, members of the Johns Hopkins Alternative Protein Project - Norah Sadowski, Lauren Blake, Mackenzie Simon-Collins, Mc Millan Ching, Ja...
Boston Biotech Series: Industry Postdocs
28 Jun 2021
Contributed by Lukas
Paul Yourik, Ph.D., is a Scientist at Moderna, a pioneering mRNA technology platform company specializing in vaccine and therapeutic development for a...
Ideating, Funding and Building Transformative Life Science Companies
13 Jun 2021
Contributed by Lukas
Dr. Cristoph Lengauer Ph.D MBA is a Partner at Third Rock Ventures, an innovative venture capital firm focused on company creation, and supporting e...
John Valliere-Douglass - Industry R&D Career Development
31 May 2021
Contributed by Lukas
John Valliere-Douglass is the Associate Director and Mass Spectrometry Core Group Leader at Seagen (formerly, Seattle Genetics). John works in the Ana...
Boston Biotech Series: Working in Consulting and Marketing Yourself on LinkedIn
16 May 2021
Contributed by Lukas
Helena Zec, PhD is an Engagement Manager at Clearview Healthcare Partners, a leader in the life science and healthcare consulting space. Helena has he...
Hopkins Biotech Network: Digitalization of Biotechnology
09 May 2021
Contributed by Lukas
Cindy Hoots is the Chief Digital Officer and CIO at AstraZeneca, a world leader in biopharmaceutical drug development. Cindy shares her thoughts on ho...
Nick Edwards - Career Decisions in Academia and Industry
03 May 2021
Contributed by Lukas
Nick Edwards, PhD is currently the Chief of Staff to the CSO at Resilience, a privately-held manufacturing and technology company devoted to building ...
Boston Biotech Series: Pitching Ideas & Leading a Biotech to FDA Approval
18 Apr 2021
Contributed by Lukas
Michael Kauffman, MD/PhD is the Founder & CEO of Karyopharm, a pharmaceutical company that develops & commercializes various drugs directed ag...
Peter Kolchinsky - A New Prescription for Innovative and Affordable Medicines
04 Apr 2021
Contributed by Lukas
Peter Kolchinsky, PhD, is a Managing Partner at RA Capital Management, a multi-stage investment manager dedicated to evidence-based investing in pub...
JHGCC: The Academia to Industry Transition
28 Mar 2021
Contributed by Lukas
Vania Cao, Ph.D is the Founder of Free The PhD, an educational platform designed to help late-stage STEM PhDs successfully break into the job market. ...
Boston Biotech Series: Career Transitions and Networking in Biotech
22 Mar 2021
Contributed by Lukas
Michael Ehlers, MD/PhD, is the CSO and Venture Partner at Apple Tree Partners, a life sciences venture capital firm that creates and invests in biotec...
JHGCC: Cracking the Case with Bain & Co.
14 Mar 2021
Contributed by Lukas
In this episode, an esteemed panel of four from Bain & Company - Bobbi Lambros (Recruiting Manager, North America), Amir Niaki (Consultant, DC), N...
Miranda Broz - Developing Cancer Immunotherapies
08 Mar 2021
Contributed by Lukas
Miranda Broz, PhD is the Scientific Associate Director of Discovery Myeloid Biology at Bristol Myers Squibb’s R&D site in Redwood City, Californ...
Boston Biotech Series: Career Opportunities in Biotech
22 Feb 2021
Contributed by Lukas
Melissa Stundick, PhD is the VP of Business Development at Spero Therapeutics, a clinical-stage biotech company that develops treatments for multidrug...
Jo Bhakdi - Early Cancer Detection
08 Feb 2021
Contributed by Lukas
Jo Bhakdi is the Founder & CEO of Quantgene, an early-stage medical technology company that deploys machine learning & advanced genetic sequen...
Boston Biotech Series: Overview of Boston Biotech
25 Jan 2021
Contributed by Lukas
This episode is part of the Boston Biotech Series - produced in collaboration with the Professional Development & Career Office (PDCO) at the John...
Jeff Galvin - Programming a HIV Functional Cure
11 Jan 2021
Contributed by Lukas
Jeff Galvin is the CEO & Founder of American Gene Technologies (AGT), a clinical-stage biotech company with a proprietary gene-delivery platform f...
Drs. Paul Hergenrother & Rebecca Lee Smith - COVID-19 Testing & Tracing
14 Dec 2020
Contributed by Lukas
Dr. Paul Hergenrother, PhD is a Professor of Chemistry at the University of Illinois at Urbana-Champaign (UIUC), whose organic chemistry lab character...
Bijal Trivedi - History of Cystic Fibrosis
30 Nov 2020
Contributed by Lukas
Bijal Trivedi, MS is an award-winning journalist and author of Breath from Salt, a book about the history of cystic fibrosis (CF). Breath from Salt is...
Daniel Pham - Informing Philanthropic Investments
16 Nov 2020
Contributed by Lukas
Dr. Daniel Pham, PhD is an Associate Director at the Milken Institute’s Center for Strategic Philanthropy, which works with a diverse array of key s...
Florian Krammer - COVID-19 Vaccine Development
02 Nov 2020
Contributed by Lukas
Dr. Florian Krammer, PhD is a Professor of Vaccinology in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai in New York Ci...
Camille Delebecque - Building Synthetic Biology Companies
26 Oct 2020
Contributed by Lukas
Dr. Camille Delebecque, M.Sc., PhD is Co-Founder & CEO of Afineur, a company that sustainably processes raw agriculture into plant-based meats and...
Jason Howard - Connecting Biotech & Physicians
19 Oct 2020
Contributed by Lukas
Dr. Jason Howard, PhD is a Medical Science Liaison at Sanofi/Genzyme, where he provides field support for a metastatic prostate cancer treatment (caba...
Don Anderson & Caroline Vissers - Applying Hypoxia Biology
05 Oct 2020
Contributed by Lukas
Dr. Don Anderson, PhD, MBA is Senior Scientist at Merck & Co., a multinational pharmaceutical company that develops and manufactures medicines in ...
Elias Davis - Investing & Skill Building
21 Sep 2020
Contributed by Lukas
Elias Davis is Principal at Kli Capital, a generalist venture capital firm based out of New York City with a focus on investing in early-stage compani...
Max Tejada - Biologics & Bioassays
08 Sep 2020
Contributed by Lukas
Max Tejada, PhD is Senior Director at Kite Pharma, an American biotech company and subsidiary of Gilead Sciences that develops cancer immunotherapies ...
Ernesto Chanona - Business & Relationship Building
24 Aug 2020
Contributed by Lukas
Ernesto Chanona, PhD is Senior Manager in the Office of BioHealth and Life Sciences at the Maryland Department of Commerce, which fosters growth of l...
Janice Logan - Patenting Scientific Insights
10 Aug 2020
Contributed by Lukas
Dr. Janice Logan, PhD, JD is an alumna of the Johns Hopkins PhD program in Biomedical Engineering and Partner at Morgan Lewis, a prominent law firm th...
Evan Guggenheim - Emerging Cell & Gene Therapies
27 Jul 2020
Contributed by Lukas
Evan Guggenheim, PhD is Executive Director & Head of Research Operations at Sana Biotechnology, a startup dedicated to developing stem cell therap...
Roshni Rao - International Students & Life Design
13 Jul 2020
Contributed by Lukas
Roshni Rao, PhD is Director of the PHutures Office at Johns Hopkins University, where she works with PhDs and postdocs to supplement academic training...
Lauren Lee - Biotech Investing
29 Jun 2020
Contributed by Lukas
Lauren Lee, Ph.D is an Associate at Solasta Ventures, the U.S. subsidiary of South Korean venture capital firm Aju IB that focuses on investments in t...
Bernat Navarro-Serer - Shaping Science Policy
15 Jun 2020
Contributed by Lukas
Bernat Navarro-Serer is the Eastern Hub Co-Chair of the National Science Policy Network (NSPN), a non-profit organization that equips scientists with ...
Sam Hong - Running a Pharmaceutical Startup
01 Jun 2020
Contributed by Lukas
Sam Hong, Ph.D is the Chief Operating Officer (COO) at Rapafusyn Pharmaceuticals, a pre-clinical stage startup developing macrocycle-based therapeutic...
Academia or Industry?
21 May 2020
Contributed by Lukas
We discuss that familiar career question, "academia or industry?" as well as introduce the goals of the podcast and backgrounds of the hosts...